The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera

<table>Enrollment trend during the first 2 years. The double line represent the theoretical enrollment trend. The  dotted line shows the real enrollment trend, and the straight one represents the future trend to reach the established sample size.</table>

Thrombosis

fig2

Figure 2

Figure 2: The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera 

Figure 2 | The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera 